Viewing Study NCT01262235


Ignite Creation Date: 2025-12-24 @ 10:37 PM
Ignite Modification Date: 2026-01-13 @ 11:33 AM
Study NCT ID: NCT01262235
Status: COMPLETED
Last Update Posted: 2019-01-16
First Post: 2010-12-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Dose Finding Study of TKM-080301 Infusion in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) Patients
Sponsor: Arbutus Biopharma Corporation
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: TKM-PLK1-001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators